Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mangoni

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Chemotherapy (Florence, Italy)|November 26, 2009
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancerL Livi, C Saieva, S Borghesi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2014
Impact of sentinel node tumor burden on outcome of invasive breast cancer patientsI Meattini, I Desideri, C Saieva, et al.
Journal of Chemotherapy (Florence, Italy)|May 4, 2010
Adjuvant trastuzumab in breast cancer: experience from the University of FlorenceL Livi, S Borghesi, I Meattini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 25, 2022
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancerM Loi, G Salvatore, M Sottili, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2007
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgeryL Livi, M Stefanacci, S Scoccianti, et al.
La Radiologia Medica|January 30, 2013
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experienceD Greto, F Paiar, C Saieva, et al.
Biomed Research International|July 8, 2014
Hypofractionation in prostate cancer: radiobiological basis and clinical applianceM Mangoni, I Desideri, B Detti, et al.
Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.
La Radiologia Medica|August 9, 2012
Treatment of invasive male breast cancer: a 40-year single-institution experienceIcro Meattini, L Livi, D Franceschini, et al.
Clinical & Experimental Metastasis|August 19, 2021
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)G Francolini, M Loi, V Salvestrini, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Chemotherapy (Florence, Italy)|November 26, 2009
Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancerL Livi, C Saieva, S Borghesi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 3, 2014
Impact of sentinel node tumor burden on outcome of invasive breast cancer patientsI Meattini, I Desideri, C Saieva, et al.
Journal of Chemotherapy (Florence, Italy)|May 4, 2010
Adjuvant trastuzumab in breast cancer: experience from the University of FlorenceL Livi, S Borghesi, I Meattini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 25, 2022
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancerM Loi, G Salvatore, M Sottili, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2007
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgeryL Livi, M Stefanacci, S Scoccianti, et al.
La Radiologia Medica|January 30, 2013
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experienceD Greto, F Paiar, C Saieva, et al.
Biomed Research International|July 8, 2014
Hypofractionation in prostate cancer: radiobiological basis and clinical applianceM Mangoni, I Desideri, B Detti, et al.
Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.
La Radiologia Medica|August 9, 2012
Treatment of invasive male breast cancer: a 40-year single-institution experienceIcro Meattini, L Livi, D Franceschini, et al.
Clinical & Experimental Metastasis|August 19, 2021
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)G Francolini, M Loi, V Salvestrini, et al.
Pageof 3